ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 993,77
0,45%
Dow Jones
38 776,59
0,26%
DAX
18 157,36
0,91%
Brent Oil
83,525
0,48%
Bitcoin
63 650,30
-0,54%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Novavax Inc (NVAX)

  7. Novavax Inc (NVAX) Actualités

NVAX

Novavax (NVAX)

Novavax Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NVAX
DateHeureSourceTitreSymboleSociété
06/05/202412h22GlobeNewswire Inc.Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual MeetingNASDAQ:NVAXNovavax Inc
15/04/202412h00GlobeNewswire Inc.Shah Capital nominates two highly qualified independent director candidates for NovavaxNASDAQ:NVAXNovavax Inc
01/04/202414h00PR Newswire (US)Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024NASDAQ:NVAXNovavax Inc
06/03/202401h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
29/02/202422h02PR Newswire (US)Novavax to Participate in TD Cowen's 44th Annual Health Care ConferenceNASDAQ:NVAXNovavax Inc
28/02/202414h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
28/02/202414h00PR Newswire (US)Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
28/02/202413h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NVAXNovavax Inc
23/02/202414h03IH Market NewsGoldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in Pre-Market, and MoreNASDAQ:NVAXNovavax Inc
22/02/202412h00PR Newswire (US)Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase AgreementNASDAQ:NVAXNovavax Inc
20/02/202415h25PR Newswire (US)Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024NASDAQ:NVAXNovavax Inc
03/01/202415h25PR Newswire (US)Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:NVAXNovavax Inc
18/12/202314h00PR Newswire (US)Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in TaiwanNASDAQ:NVAXNovavax Inc
13/12/202323h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
13/12/202314h31Dow Jones NewsModerna Shares, Other Covid Vaccine Makers Hit by Warning From PfizerNASDAQ:NVAXNovavax Inc
13/12/202314h00PR Newswire (Canada)Canadians Can Help Protect Loved Ones as We Head into the Holiday SeasonNASDAQ:NVAXNovavax Inc
05/12/202322h01PR Newswire (US)Novavax's Updated COVID-19 Vaccine Now Authorized in CanadaNASDAQ:NVAXNovavax Inc
28/11/202319h13IH Market NewsWall Street Radar: Amazon, Blackrock, General Motors, Eli Lilly, Novavax..NASDAQ:NVAXNovavax Inc
28/11/202312h00PR Newswire (US)Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health OrganizationNASDAQ:NVAXNovavax Inc
17/11/202313h15PR Newswire (US)Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic PrioritiesNASDAQ:NVAXNovavax Inc
10/11/202315h25PR Newswire (US)Novavax to Participate in Jefferies London Healthcare ConferenceNASDAQ:NVAXNovavax Inc
09/11/202314h00PR Newswire (US)Novavax Reports Third Quarter 2023 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
09/11/202313h32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVAXNovavax Inc
09/11/202313h02IH Market NewsThursday’s Wall Street Highlights: Nvidia, Duolingo, Disney, Virgin Galactic, Applovin, and moreNASDAQ:NVAXNovavax Inc
08/11/202312h59IH Market NewsWednesday’s Wall Street Highlights: Spirit AeroSystems, Upstart, Toast, Upwork, Take-Two, Sleep Number, and moreNASDAQ:NVAXNovavax Inc
02/11/202322h00Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NVAXNovavax Inc
02/11/202314h25PR Newswire (US)Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023NASDAQ:NVAXNovavax Inc
31/10/202321h48PR Newswire (US)Novavax's Updated COVID-19 Vaccine Now Approved in the EUNASDAQ:NVAXNovavax Inc
31/10/202318h08PR Newswire (US)Novavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EUNASDAQ:NVAXNovavax Inc
18/10/202314h05PR Newswire (US)Novavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid™ ▼ in United KingdomNASDAQ:NVAXNovavax Inc
 Showing the most relevant articles for your search:NASDAQ:NVAX

Dernières Valeurs Consultées

SPI
SP500
S&P 500
FTSE
UKX
FTSE 100
NASDAQ
AMZN
Amazon.com
EU
DG
Vinci
EU
AF
Air FranceKLM
EU
MC
Lvmh Moet Hennessy Louis...
EU
AI
Air Liquide
EU
GLE
Societe Generale
NASDAQ
NVDA
NVIDIA
EU
ML
Michelin
EU
BNP
BNP Paribas
EU
RNO
Renault
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés